On Monday analysts at Citi Research downgraded shares of The Clorox Co. CLX to Neutral from Buy and maintained the $101 price target.
Wendy Nicholson outlined concerns moving forward.
Clorox is expected to post low to mid single digit EPS growth in fiscal year 2015 compared to double digit expected growth from its peers.
Analysts feel the stock has moved further than is should have on the recent news stories and the stock is not trading ahead of its fundamentals.
Lastly, Clorox is facing intense competition for its market share and product categories.
Shares of Clorox recently traded at $95.72 down 1.55 percent.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.